Application Note: Profiling and Quantitation of Metabolomic 'Signatures' for Breast Cancer Cell Progression
1 May 2013

Metabolic reprogramming is required both during the initial breast cancer transformation process (primary tumor) and during the acquisition of metastatic potential (metastases). Staging of the metabolic reprogramming using metabolomics, could pinpoint metabolic processes essential for transformation and invasiveness and has the potential to yield biomarkers and new directions for therapeutics. This application note presents a study of combining targeted and untargeted approach for cancer biomarkers analysis.

Download PDF >>PDF Icon

Read the full article...

  Become a member
  • Quick and complete access to all application articles

  • Download 10,000+
    applications and methods

  • Make informed buying decisions


Already a member?

Log in for full access to the article




Remember me

Company